These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22444690)
1. Elevated HIF-1α expression of acute myelogenous leukemia stem cells in the endosteal hypoxic zone may be a cause of minimal residual disease in bone marrow after chemotherapy. Matsunaga T; Imataki O; Torii E; Kameda T; Shide K; Shimoda H; Kamiunten A; Sekine M; Taniguchi Y; Yamamoto S; Hidaka T; Katayose K; Kubuki Y; Dobashi H; Bandoh S; Ohnishi H; Fukai F; Shimoda K Leuk Res; 2012 Jun; 36(6):e122-4. PubMed ID: 22444690 [No Abstract] [Full Text] [Related]
2. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433 [TBL] [Abstract][Full Text] [Related]
3. Hematopoietic progenitor cell mobilization results in hypoxia with increased hypoxia-inducible transcription factor-1 alpha and vascular endothelial growth factor A in bone marrow. Lévesque JP; Winkler IG; Hendy J; Williams B; Helwani F; Barbier V; Nowlan B; Nilsson SK Stem Cells; 2007 Aug; 25(8):1954-65. PubMed ID: 17478585 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia and expression of hypoxia-related proteins in acute myeloid leukemia. Fiegl M; Spiekermann K Leuk Res; 2011 May; 35(5):573-4. PubMed ID: 21163529 [No Abstract] [Full Text] [Related]
5. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia. Niu J; Li H; Zhang Y; Li J; Xie M; Li L; Qin X; Qin Y; Guo X; Jiang Q; Liu Y; Chen S; Huang X; Han W; Ruan G Leuk Res; 2011 Jun; 35(6):771-6. PubMed ID: 21168207 [TBL] [Abstract][Full Text] [Related]
6. Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models. Portwood S; Lal D; Hsu YC; Vargas R; Johnson MK; Wetzler M; Hart CP; Wang ES Clin Cancer Res; 2013 Dec; 19(23):6506-19. PubMed ID: 24088735 [TBL] [Abstract][Full Text] [Related]
8. Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenance. Vukovic M; Guitart AV; Sepulveda C; Villacreces A; O'Duibhir E; Panagopoulou TI; Ivens A; Menendez-Gonzalez J; Iglesias JM; Allen L; Glykofrydis F; Subramani C; Armesilla-Diaz A; Post AE; Schaak K; Gezer D; So CW; Holyoake TL; Wood A; O'Carroll D; Ratcliffe PJ; Kranc KR J Exp Med; 2015 Dec; 212(13):2223-34. PubMed ID: 26642852 [TBL] [Abstract][Full Text] [Related]
9. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
10. Correlation of WT1 expression with the burden of total and residual leukemic blasts in bone marrow samples of acute myeloid leukemia patients. Alonso-Dominguez JM; Tenorio M; Velasco D; Abalo L; Lozano S; Villarrubia J; López-Jimenez J; Grande S; Ayala R Cancer Genet; 2012 Apr; 205(4):190-1. PubMed ID: 22559982 [No Abstract] [Full Text] [Related]
11. Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent. Song LP; Zhang J; Wu SF; Huang Y; Zhao Q; Cao JP; Wu YL; Wang LS; Chen GQ Oncogene; 2008 Jan; 27(4):519-27. PubMed ID: 17637739 [TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
14. Mutual regulation of hypoxic and retinoic acid related signalling in tubular proximal cells. Fernández-Martínez AB; Jiménez MI; Hernández IS; García-Bermejo ML; Manzano VM; Fraile EA; de Lucio-Cazaña FJ Int J Biochem Cell Biol; 2011 Aug; 43(8):1198-207. PubMed ID: 21554977 [TBL] [Abstract][Full Text] [Related]
15. An evidence for adhesion-mediated acquisition of acute myeloid leukemic stem cell-like immaturities. Funayama K; Shimane M; Nomura H; Asano S Biochem Biophys Res Commun; 2010 Feb; 392(3):271-6. PubMed ID: 20060807 [TBL] [Abstract][Full Text] [Related]
16. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment? Muntean AG; Hess JL Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728 [TBL] [Abstract][Full Text] [Related]
17. FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression. Jin G; Matsushita H; Asai S; Tsukamoto H; Ono R; Nosaka T; Yahata T; Takahashi S; Miyachi H Biochem Biophys Res Commun; 2009 Dec; 390(3):1001-6. PubMed ID: 19853583 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms. Guo M; Song LP; Jiang Y; Liu W; Yu Y; Chen GQ Apoptosis; 2006 Jan; 11(1):67-77. PubMed ID: 16374551 [TBL] [Abstract][Full Text] [Related]
19. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Kaidi A; Qualtrough D; Williams AC; Paraskeva C Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642 [TBL] [Abstract][Full Text] [Related]
20. The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities. Bruno S; Mancini M; De Santis S; Monaldi C; Cavo M; Soverini S Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]